Tobin James R insider trades
Tobin James R has filed 29 Form 4s with the SEC that we hold, for TransMedics Group, Inc. (TMDX) (Director), Globus Medical INC (GMED) (Director) and Lyra Therapeutics, Inc. (LYRA) (Director). Across all of them we count 0 purchases worth $0 and 22 sales worth $17.8M reported on Form 4. In the last 12 months: 0 purchases ($0) and 1 sale ($2.2M). The largest single trade was a sale of 30,000 shares of Globus Medical INC worth $2.2M, dated 2026-09-15. Of 1 sale filed since we began reading the 10b5-1 checkbox, 0 (0%) were marked as made under a 10b5-1 trading plan. The first filing on our record is dated 2021-12-16 and the latest 2026-09-16.
TransMedics Group, Inc. (TMDX)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2022-05-04 | S, sale reported on Form 4 | 48,516 | $1.5M | 2022-05-06 |
| 2022-07-05 | S, sale reported on Form 4 | 48,515 | $1.7M | 2022-07-06 |
| 2022-07-29 | S, sale reported on Form 4 | 48,515 | $1.9M | 2022-08-01 |
| 2023-02-23 | S, sale reported on Form 4 | 10,000 | $751.3K | 2023-02-27 |
| 2023-11-28 | S, sale reported on Form 4 | 10,000 | $701.4K | 2023-11-29 |
| 2024-03-01 | S, sale reported on Form 4 | 200 | $16.3K | 2024-03-05 |
| 2024-03-01 | S, sale reported on Form 4 | 4,234 | $350.7K | 2024-03-05 |
| 2024-03-01 | S, sale reported on Form 4 | 5,746 | $480.5K | 2024-03-05 |
| 2024-03-01 | S, sale reported on Form 4 | 2,900 | $245.7K | 2024-03-05 |
| 2024-03-01 | S, sale reported on Form 4 | 300 | $25.6K | 2024-03-05 |
| 2024-05-01 | S, sale reported on Form 4 | 11,236 | $1.2M | 2024-05-03 |
| 2024-05-01 | S, sale reported on Form 4 | 1,704 | $182.1K | 2024-05-03 |
| 2024-05-01 | S, sale reported on Form 4 | 2,000 | $220.0K | 2024-05-03 |
| 2024-05-01 | S, sale reported on Form 4 | 100 | $10.8K | 2024-05-03 |
| 2024-05-03 | S, sale reported on Form 4 | 6,895 | $863.7K | 2024-05-07 |
| 2024-05-03 | S, sale reported on Form 4 | 5,130 | $640.0K | 2024-05-07 |
| 2024-08-08 | S, sale reported on Form 4 | 7,336 | $1.2M | 2024-08-09 |
| 2024-08-08 | S, sale reported on Form 4 | 12,664 | $2.0M | 2024-08-09 |
Globus Medical INC (GMED)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2022-03-08 | S, sale reported on Form 4 | 4,484 | $322.8K | 2022-03-10 |
| 2022-03-10 | S, sale reported on Form 4 | 10,000 | $700.4K | 2022-03-10 |
| 2022-03-15 | S, sale reported on Form 4 | 8,850 | $579.4K | 2022-03-17 |
| 2026-09-15 | S, sale reported on Form 4 | 30,000 | $2.2M | 2026-09-16 |
Lyra Therapeutics, Inc. (LYRA)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1190128) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms